Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Annals of the Rheumatic Diseases
|
November 27, 2010
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials
Marleen G H van de Sande, Danielle M Gerlag, Beatrijs M Lodde, et al.
The Journal of Rheumatology
|
June 3, 2011
Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease
Rodolfo Pérez Alamino, José A Maldonado Cocco, Gustavo Citera, et al.
RMD Open
|
March 8, 2020
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
Jose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, et al.
RMD Open
|
November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe
Søren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Acta Reumatologica Portuguesa
|
July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update
Pedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Scientific Reports
|
August 13, 2025
Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt
Helena Santos, Ana Rita Henriques, Helena Canhão, et al.
Acta Reumatologica Portuguesa
|
August 10, 2018
The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy
Elsa Vieira-Sousa, Helena Canhão, Pedro Alves, et al.
Rheumatology (Oxford, England)
|
September 1, 2014
DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt
Fernando M Martins, José António Pereira da Silva, Maria José Santos, et al.
Annals of the Rheumatic Diseases
|
March 21, 2020
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Elsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, et al.
Acta Reumatologica Portuguesa
|
November 28, 2015
PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE
Elsa Vieira-Sousa, Pedro M Machado, José Costa, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Annals of the Rheumatic Diseases
|
November 27, 2010
Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials
Marleen G H van de Sande, Danielle M Gerlag, Beatrijs M Lodde, et al.
The Journal of Rheumatology
|
June 3, 2011
Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease
Rodolfo Pérez Alamino, José A Maldonado Cocco, Gustavo Citera, et al.
RMD Open
|
March 8, 2020
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
Jose Marona, Alexandre Sepriano, Santiago Rodrigues-Manica, et al.
RMD Open
|
November 30, 2018
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe
Søren Andreas Just, Frances Humby, Hanne Lindegaard, et al.
Acta Reumatologica Portuguesa
|
July 12, 2012
Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis--December 2011 update
Pedro Machado, Alexandra Bernardo, Ana Rita Cravo, et al.
Scientific Reports
|
August 13, 2025
Sociodemographic factors and biologic therapy exposure impacting health-related quality of life in psoriatic arthritis - findings from a nationwide registry Reuma.pt
Helena Santos, Ana Rita Henriques, Helena Canhão, et al.
Acta Reumatologica Portuguesa
|
August 10, 2018
The GO-DACT protocol: a multicentre, randomized, double-blind, parallel-group study to compare the efficacy of golimumab in combination with methotrexate (MTX) versus MTX monotherapy
Elsa Vieira-Sousa, Helena Canhão, Pedro Alves, et al.
Rheumatology (Oxford, England)
|
September 1, 2014
DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt
Fernando M Martins, José António Pereira da Silva, Maria José Santos, et al.
Annals of the Rheumatic Diseases
|
March 21, 2020
GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Elsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, et al.
Acta Reumatologica Portuguesa
|
November 28, 2015
PORTUGUESE RECOMMENDATIONS FOR THE USE OF BIOLOGICAL THERAPIES IN PATIENTS WITH PSORIATIC ARTHRITIS--2015 UPDATE
Elsa Vieira-Sousa, Pedro M Machado, José Costa, et al.
Page
of 7